Zymeworks ZYME
NASDAQ ZYME
$29.19 -0.71 (-2.37%)
As of: Sep 4, 2026 · 3:59 PM EDT

Zymeworks (ZYME) Change in Acquisitions & Divestments (2022 - 2026)

Zymeworks (ZYME) posted Change in Acquisitions & Divestments of $70.2 million for Q1 2026, up 11.54% sequentially from $62.9 million in Q4 2025, and up 50.75% YoY from $46.6 million in Q1 2025.

Analysis

Zymeworks (ZYME) Change in Acquisitions & Divestments (2022 - 2026) Analysis & Trends

Zymeworks has reported Change in Acquisitions & Divestments for 5 years, with the latest figure at $70.2 million in Q1 2026.

  • Quarterly Change in Acquisitions & Divestments rose 50.75% year-over-year to $70.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $248.7 million (down 20.36% YoY) and the FY2025 annual result came in at $225.1 million, down 30.87% from the prior year.
  • Change in Acquisitions & Divestments climbed to $70.2 million in Q1 2026 per ZYME's latest filing, from $62.9 million in the prior quarter.
  • Over five years, Change in Acquisitions & Divestments peaked at $125.9 million in Q3 2024 and troughed at -$46.2 million in Q4 2022.
  • A 5-year average of $64.5 million and a median of $62.3 million in 2023 frame the typical range for Change in Acquisitions & Divestments.
  • The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments jumped 234.96% in 2023, then sank 71.55% in 2025.
  • Over 5 years, Change in Acquisitions & Divestments stood at -$46.2 million in 2022, then surged by 234.96% to $62.3 million in 2023, then slipped by 23.11% to $47.9 million in 2024, then jumped by 31.29% to $62.9 million in 2025, then advanced by 11.54% to $70.2 million in 2026.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods registered $70.2 million, $62.9 million, and $35.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Zymeworks 2.13 Bn 1.86 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 79.61 Mn
Mar 31, 2026 70.18 Mn
Dec 31, 2025 62.92 Mn
Sep 30, 2025 35.83 Mn
Jun 30, 2025 79.78 Mn
Mar 31, 2025 46.55 Mn
Dec 31, 2024 47.92 Mn
Sep 30, 2024 125.95 Mn
Jun 30, 2024 91.85 Mn
Mar 31, 2024 59.85 Mn
Dec 31, 2023 62.33 Mn
Sep 30, 2023 119.20 Mn
Jun 30, 2023 124.33 Mn
Mar 31, 2023 44.22 Mn
Dec 31, 2022 -46.18 Mn
Sep 30, 2022 43.14 Mn